These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23874629)

  • 1. Health disparities from economic burden of diabetes in middle-income countries: evidence from México.
    Arredondo A; Reyes G
    PLoS One; 2013; 8(7):e68443. PubMed ID: 23874629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.
    Arredondo A; Zúñiga A
    Diabetes Care; 2004 Jan; 27(1):104-9. PubMed ID: 14693974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cost of diabetes in Latin America: evidence from Mexico].
    Arredondo A; De Icaza E
    Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.
    Arredondo A; Aviles R
    PLoS One; 2015; 10(3):e0118611. PubMed ID: 25781625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and challenges in diabetes for middle-income countries: Evidence from Mexico.
    Arredondo A; Orozco E; Duarte MB; Cuadra M; Recaman AL; Azar A
    Glob Public Health; 2019 Feb; 14(2):227-240. PubMed ID: 30068257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.
    Arredondo A; Orozco E; Alcalde-Rabanal J; Navarro J; Azar A
    Rev Saude Publica; 2018; 52():23. PubMed ID: 29489993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003].
    Arredondo A
    Rev Invest Clin; 2001; 53(5):422-9. PubMed ID: 11795108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
    Arredondo A; Zúñiga A; Parada I
    Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.
    Arredondo A; Cuadra SM; Duarte MB
    BMC Public Health; 2015 Nov; 15():1106. PubMed ID: 26546356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.
    Arredondo A; Azar A; Recamán AL
    Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico.
    Arredondo A; Zúñiga A
    Am J Hypertens; 2006 Jun; 19(6):553-9. PubMed ID: 16733225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.
    Arredondo A; Duarte MB; Cuadra SM
    Int J Health Plann Manage; 2017 Apr; 32(2):e121-e136. PubMed ID: 27238949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico.
    Arredondo A; Azar A; Recaman AL
    Global Health; 2018 Aug; 14(1):89. PubMed ID: 30143010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
    Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S
    Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital care direct costs due to ambulatory care sensitive conditions related to diabetes mellitus in the Mexican public healthcare system.
    Saturno-Hernández P; Moreno-Zegbe E; Poblano-Verastegui O; Torres-Arreola LDP; Bautista-Morales AC; Maya-Hernández C; Uscanga-Castillo JD; Flores-Hernández S; Gómez-Cortez PM; Vieyra-Romero WI
    BMC Health Serv Res; 2024 Apr; 24(1):507. PubMed ID: 38659025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico.
    Arredondo A; Zuñiga A
    Cad Saude Publica; 2012 Mar; 28(3):497-502. PubMed ID: 22415182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs and financial consequences of the changing epidemiological profile in Mexico.
    Arredondo A
    Health Policy; 1997 Oct; 42(1):39-48. PubMed ID: 10173492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of health systems on diabetes care in low and lower middle income countries.
    Beran D
    Curr Diab Rep; 2015 Apr; 15(4):20. PubMed ID: 25721248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic Costs of Diabetes in the U.S. in 2017.
    American Diabetes Association
    Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.